Primer: Checkpoint Therapeutics (CKPT US) - Aug 2026
Checkpoint Therapeutics is a clinical-stage biopharmaceutical company on the cusp of commercialization, with its lead drug, cosibelimab...
103 Views
Biopharma Week in Review - March 17, 2025
Trump’s pick for CDC director, former Congressman Dave Weldon, had his nomination withdrawn just hours before the Senate committee hearing.
305 Views
APAC Healthcare Weekly (Mar 16)- Celltrion, Ono Pharma, Sun Pharma, Syngene, Zydus, Sichuan Kelun
APAC healthcare companies continued to get approvals for new products and initiates clinical trials. The companies continued with acquisitions and...
639 Views
Biopharma Week in Review - January 6, 2025
On the obesity front, NVO’s CagriSema fell short of expectations, while the FDA reaffirmed LLY’s GLP-1 shortage resolution, bearing bad news for...
320 Views
How Acquiring Checkpoint Therapeutics Inc Adds Value to Sun Pharma?
Sun Pharma to acquire Checkpoint Therapeutics for $355 million, boosting onco-dermatology portfolio with FDA-approved UNLOXCYT™, gaining access to...
573 Views